A recent media report said epinephrine auto-injectors are in short supply and/or not available nationwide. This report is incorrect. The report has led to panic among many living with food allergies.
Any such report is a gross misinterpretation. A nationwide notice came out that says some forms of epinephrine are in short supply. Epinephrine is a life-saving treatment for severe allergic reactions to food or other allergens. Patients at risk for anaphylaxis carry pre-loaded auto-injectors. The epinephrine shortage DOES NOT include EpiPen™ or Auvi-Q™ auto-injectors.
The shortage specifically states that the ONLY products affected are:
- 1 mg/mL ampules and multi-dose vials, and
- 0.1 mg/mL preloaded 10 mL syringes
- Used by hospitals, physician offices and emergency medical services.
We have confirmed with both Mylan and Sanofi, the makers of EpiPen and Auvi-Q:
- There is NO national shortage of these products, at either pediatric (0.15 mg) or adult (0.3 mg) dosages.
We remain committed to providing accurate information for the millions of people living with allergic conditions. We hope to continue to serve as a resource of timely evidence-based information now and in the future.
As always, contact your physician or allergist with any questions specific to your medical care.
David Stukus, MD
Chair, Food Allergy and Anaphylaxis Subcommittee of the Medical/Scientific Council for the Asthma and Allergy Foundation of America
Secretary, Board of Directors, Asthma and Allergy Foundation of America